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FROM THE EDITORS

Activating Patient Involvement

“When patients and their families are educated and understand why and how they need to
actively participate in their care, and when they feel empowered to do so, their involvement can
help to prevent medical errors and enhance safety.”1 This is the central theme of two important
new books, Patients as Partners: How to Involve Patients and Families in Their Own Care,
by Meghan McGreevey, and You: The Smart Patient, An Insider’s Handbook for Getting the Best
Treatment, by Michael F. Roizen, MD and Mehmet C. Oz, MD.
Both books are quick to point out that countless medical errors occur and that a great majority
of them are preventable. Roizen and Mehmet reveal that “you have a 1 in 25 chance of
developing a serious unexpected complication (such as a fatal infection) when you check into the
hospital…[and] your odds of being affected by that potentially deadly, unforeseen complication
might be as high as 2 in 5.”2 McGreevey asserts that “more than two in five, or 42%, of adults’
lives have been touched by a medical error in some way.”1 Both also go on to report that about
70%-75% of these complications or medical errors are completely preventable. These books are
unique and important because in addition to exposing many of the frailties that exist in the health
care system, they take the next crucial step towards preventing these errors by providing people
the knowledge they need to actively participate in their own care.
Patients as Partners is essentially a “how to” book for physicians to get their patients more
involved in their own care. The book is written in the typical Joint Commission Resources
(JCR) manuscript style, and is worth reading because it provides many relevant and provocative
examples that illustrate its main point—why it’s so crucial to engage patients and how that goal
can be achieved. The book covers everything from defining a culture of safety and explaining its
importance; to learning how to communicate with patients, including specific techniques
clinicians can use in their daily practice (e.g., putting patients at ease, initiating conversations,
communicating with patients and their patient advocates, and gauging patient understanding);
to current efforts aimed at getting patients more involved (e.g., the Speak Up campaign).
The strength of this book rests with the many examples it provides. It offers several informative
case studies, such as the accidental death of a Boston Globe reporter at the Dana-Farber Cancer
Institute and how this incident showed that “active patient involvement improves the quality of
care, enhances patient self-esteem, increases patient safety, and reduces the potential for medical
errors.”1 The book also contains patient perspectives, like the story of how Roxanne Goeltz and
her struggle to be an active participant in her own cancer treatment underlies the importance of
effective communication skills. As the situation revealed, “when a patient feels mistrustful and
afraid of medical institutions and physicians, yet wants to participate fully in his or her health care,
not being able to do so may be frustrating, demoralizing, and anxiety provoking.”1 The book also
offers many genuinely useful tips, such as specific steps one can take to be an effective patient
advocate, specific strategies for effectively communicating with patients, and methods of teaching
patients to get involved (e.g., tell patients that it is okay to ask whether caregivers/healthcare
providers have washed their hands). And finally, the book provides helpful references to web sites
of organizations that provide valuable information about patient safety and patient-centered care.
Every provider should read this book; the examples are simply too good and too poignant
to pass up. And considering that the book is also such a quick read, we think many patients
would benefit from reading this book. The only real shortcoming is that some patients might
not easily see its relevance as it focuses more on ways providers can engage patients and
not on specific things patients can do to help themselves. That job is accomplished by You:
The Smart Patient.
continued p.2

You: The Smart Patient is similar to Patients as Partners in
that it highlights many of health care’s problems, and it strives
to get patients more involved. This book, however, is geared
more towards patients, not clinicians. It is also a worthwhile
read because it offers patients concrete examples and guidance
for taking control of their own care and navigating the often
complex health care system. It does so while using humor and
entertaining illustrations. Specific topics include choosing the
right doctor; choosing the right hospital; choosing the right
insurance company; understanding prescription drugs, dealing
with clinicians; and understanding treatment options and
alternative medicines and pain management.
The strength of this book rests with its easy readability and
comprehensiveness. The book starts off with a simple quiz to
“help you gauge how much you really know about taking
control of your health care.” It includes questions like “what’s
the most important thing to bring with you to the doctor’s
office,” “when is the best time to schedule a doctor appointment,”
“how often does getting a second opinion change treatment
substantially,” “what is the biggest advantage most HMO
insurance plans have over current indemnity health-insurance
plans.” The book then goes on to systematically tackle many of
these questions. The book offers a handy glossary of medical
jargon, which is translated into layman’s terms, and sample
forms from health journals, living wills, power of attorney, “do
not resuscitate” orders. Overall, this book is an excellent “how
to” guide for patients who “in clear, easy steps [want] to take

2 June 2007

control of their own health care and deal with all matters that
may come up when facing a medical [problem].” To be frank,
every person should read this book, providers and patients alike,
as we all will be patients one day.
Regardless of whether you’re a patient or a provider, both
books are a great read. They probably won’t change your core
beliefs about the health care system. What they will do, and
what makes them so novel, is that they provide numerous ways
to effectively get patients more involved in their own care. In
our view, this level of patient activation is what real patient
centered care is all about. As usual, you can reach me at
David.Nash@jefferson.edu.
Kevin Bowman, MD
Jefferson Medical College, 2006
David B. Nash, MD, MBA
Editor
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Letters to the Editor
I read with great interest the articles by Maio et al. and Brixner
et al. in the March, 2007 issue of the Health Policy Newsletter,
concerning impact of publication of ALLHAT study results
on physician behavior. Both authors conducted retrospective
studies of large datasets – Maio, claims data for a region in
Italy, and Brixner, for a large electronic medical record primary
care database – in order to examine whether the ALLHAT
recommendations regarding first line use of thiazide-type
diuretics (THZDs) led to changing prescribing patterns. These
analyses both observe relatively small changes in prescribing
behavior and conclude that physicians are slow to adopt practice
changes based on published evidence.
Although there is a wealth of published evidence of significant
time lags in physician uptake of evidence-based guidelines and
research findings, I question whether this conclusion can be
drawn from the Maio and Brixner studies. From the limited
methodologic information available in the Newsletter reports, it
appears that neither study was able to clearly identify cases of
first line use (i.e., newly diagnosed hypertensives started on an
initial pharmacotherapy). As your own published work with
PhRMA has pointed out, by the end of the ALLHAT study
period, approximately 70 % of patients required multiple
medications to control their blood pressure. So, even if
physicians read ALLHAT reports and agreed with the findings,
they would not see the results as applicable to treatment for their
own well-established hypertensive populations, and would not
discontinue therapies if blood pressure was being adequately
controlled. In addition, as you know, ALLHAT findings were
extremely controversial and have been challenged by many
providers, professional societies, and academics.

If the evidence is reported, but not widely agreed upon or
accepted, we would not expect to see major changes in
prescribing behavior. This is very different than saying that
physicians do not change behaviors in the face of evidence.
Neil Goldfarb
Department of Health Policy, Jefferson Medical College

I just wanted to take a minute to send you an email on your
“Sunshine is the Best Disinfectant” article. I found it to be very
educational and informative. HAI has always been something
that I've run into over the course of my career in employee
benefits with shock claimants on employer groups that have had
complications and deaths due to infections happening in the
hospitals. I have also been involved in worker's compensation
claims where job related injuries progressed into hospitalization
stays where limbs were lost as result of HAI. Your article is
something that I am passing on to some of my partners who deal
with physicians and hospital groups in our area. Take care.
Raymond E. Rice
Williams-Manny Midwest

Please note: The comments expressed by the authors in
this publication do not necessarily represent the views of
the Editorial Board, Thomas Jefferson University, Jefferson
Medical College or of the Department of Health Policy.

Welcome the 2007-2008 Delaware Valley Schweitzer Fellows
We are pleased to announce the selection of our inaugural
group of Delaware Valley Schweitzer Fellows. As has been
reported in previous issues of Health Policy Newsletter, the
Albert Schweitzer Fellowship is a national program which
provides students in health-related disciplines an opportunity
to design and implement projects intended to improve the
health of underserved communities. Jefferson’s Department
of Health Policy (DHP) serves as administrative home for the
recently-launched Delaware Valley program, one of the first
expansion sites for this national initiative.
Applicants were invited from over 80 graduate programs in
the Philadelphia region, southern New Jersey, and Delaware.
With assistance of DHP faculty and members of the Program
Advisory Board, 22 applicants were screened, and 12 selected:
• Betty Chung, UMDNJ medical student, will provide
Hepatitis B education and screening in the Asian community
• Gillian Farrelly and Ivania Queseda, Drexel University
dance movement therapy students, will employ
choreography and dance to address psychosocial development
of adolescents
• Rachel Kadakia and Melessa Yee, Drexel University
medical students, will help uninsured clients of the 11th
Street Family Health Clinic apply for health insurance
• Devra Noily, a divinity student at Reconstructionist
Rabbinical College, will provide spiritual/pastoral care
to trans-gender and intersex individuals

• SuJung Park, a Drexel University medical student, will
provide health education and schoolwork assistance to
youths in homeless shelters
• Michael Rovito and Julie Tippens, in Temple University’s
Public Health program, will facilitate development of
a school-based community garden, to empower youth and
neighborhoods and promote community health and
environmental justice
• Sheila Salvant-Valentine, a physician and Widener
University health law student, will develop
cardiovascular disease education and risk reduction
programs for Delaware’s Haitian immigrant community
• Behnaz Sarrami, a Temple University podiatry student,
will provide podiatric screenings and related health
services to homeless shelter residents
• Alana Wright-Benton, studying health administration and
health education at St. Joseph’s University, will provide
education on SIDS prevention and child CPR to mothers
of newborns in community shelters
The Fellows will conduct their projects over the next year,
devoting at least 200 hours to community service over the
course of the year.
Opportunities to sponsor a Fellow are available. Please
contact Nicole Cobb, MAOM, Program Coordinator
(nicole.cobb@jefferson.edu) for more information.
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Update National
on Screening
Cancer
Veteran’s Administration
Centerfor
forColorectal
Patient Safety
Comes to Philadelphia
MONA SARFATY, MD
In July 2006, the National Commission on
accreditation, certification, and
Prevention Priorities reported that it had
recertification procedures. The work group
RESEARCH ASSISTANT PROFESSOR
ranked colorectal cancer (CRC) screening as
embraced the well-documented conclusion
DEPARTMENT OF HEALTH POLICY
one of the top four prevention priorities1-3,
that provider recommendation is pivotal in
JEFFERSON MEDICAL COLLEGE
based on the burden of clinical disease that
persuading individuals to undergo screening.9
could be prevented and cost-effectiveness.
The Roundtable published a toolbox and
The report of the Commission highlighted the importance of
guide to assist primary care physicians to improve screening rates.
prevention, and challenged those interested to head efforts to
The third group of Roundtable members focus on public
improve quality in the delivery of preventive services.
awareness, promoting CRC screening in general rather than by a
In March 2007, legislation was introduced in Congress that
would establish a national CRC screening program. It would be
supported by the Centers for Disease Control and Prevention
(CDC) through grants to states and other entities that could
reach the target populations. If established, this new federal
effort would increase access to screening for the low-income
uninsured and under-insured. Five demonstration programs
funded by the CDC and three statewide programs that have
provided free screening to low-income uninsured individuals are
providing trial runs for this program.
Recognition of the importance of CRC screening has inspired
initiation of several successful efforts to improve screening rates
over the last decade. In 2002, only seven states had screening
rates > 60%; by 2004, only two years later, 15 states were at that
level, seven had surpassed 65%.4 During the same time period,
11 states experienced increases in endoscopy screening rates of
7% or greater; two had increases of 12%.5,6 Nationwide, overall
screening rates increased by 3%.4 Medicare screening rates also
demonstrated significant increases as measured in 2000 and
2003.7 And, between 2003 and 2005, rates in Medicare managed
care plan increased from 49.5% to 53.9%; rates in commercial
managed care plans increased from 47.4% to 52.3%.8
Significant efforts have been mounted by private and public
groups to improve screening rates. The National Colorectal
Cancer Roundtable supports progress of these groups with its
strategic planning and networking activities. The Roundtable
was founded as a collaborative endeavor between the CDC
and the American Cancer Society (ACS) in 1997. Influential
groups like the Cancer Research and Prevention Foundation
(www.preventcancer.org), the Entertainment Industry Foundation
(www.eif.org), well-known cancer centers, physician
associations, and voluntary health organizations have played
major roles. The Roundtable and its nearly 50 member
organizations focus on policy, professional education, and public
awareness. Activities in each area contribute to the improving
screening rates.
The Roundtable members with a policy focus have worked
on policies that promote screening, including coverage by thirdparty payers and employer purchasing of health benefits that
include CRC screening. They worked with National Committee
for Quality Assurance (NCQA) to include a measure on CRC
screening in the Health Employer Data and Information Set
(HEDIS). As of 2006, managed care plans now report CRC
screening rates.
The Roundtable members focusing on professional education
and practice sought to stimulate interventions among providers
that increase screening. They urged associations of health
professionals to include continuing education on CRC in
4 June 2007

particular test. They recommended public education campaigns
coupled with carefully designed interventions to target
subgroups at greater risk. They endorsed the delivery of
messages by role models, celebrities, and television personalities
who could get public attention and influence behavior. In 2002,
they achieved a designation of Colorectal Cancer Awareness Month
for the month of March and developed the campaign slogan,
“preventable, treatable, beatable.” Polyp Man™ was created
and appeared in televised public service announcements. In
2006, the Warner Brothers’ Foghorn Leghorn cartoon character
spoke to the television audience (“I say, I say, don’t be a chicken,
get screened”). Many groups have taken a leadership role in
these and other public awareness initiatives, including the Cancer
Research and Prevention Foundation, the Colorectal Cancer
Alliance, the STOP Colorectal Cancer Foundation, Hadassah, the
EIF, the Jay Monahan Center, and the Eric Davis Foundation.
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A Study of Colorectal Cancer Screening in Pennsylvania
RONALD E. MYERS, PHD
cancer screening by recommended means
In January 2006, Senate Resolution 212
PROFESSOR OF MEDICINE
is more cost-effective than not screening.
directed the Pennsylvania Legislative Budget
DEPARTMENT OF MEDICAL ONCOLOGY
Further, an annual SBT is the most costand Finance Committee: A Joint Committee
MONA SARFATY, MD
effective screening approach, followed
of the Pennsylvania General Assembly to
RESEARCH ASSISTANT PROFESSOR
by a combination of SBT and flexible
conduct a study of various aspects of
sigmoidoscopy. Colonoscopy
colorectal screening. Researchers at Thomas
DEPARTMENT OF HEALTH POLICY
is less cost-effective than the other two
Jefferson University were funded to determine
THOMAS JEFFERSON UNIVERSITYYI
the state’s colorectal cancer burden, describe
alternatives, although it is certainly
screening options and their cost-effectiveness,
objectively cost-effective by the standards
determine insurance coverage for screening, and assess screening
of economic outcomes research.
capacity. The research team completed this policy study using
data collected through reviews of the scientific literature, contact
Insurance Coverage for Screening
with leading experts in the field, administration of three statewide
Insurance coverage for colorectal cancer screening is not
surveys, collection of data from the Pennsylvania Department
uniform in Pennsylvania. The majority of insurers reported
of Health, and the Pennsylvania Health Care Cost Containment
“always” covering the recommended colorectal cancer screening
Council. Findings are summarized below.
tests. The remaining insurers, however, reported that the screening

Colorectal Cancer Burden and Risk
The burden of colorectal cancer (CRC) is substantial in the
Commonwealth of Pennsylvania. The state will experience an
estimated 8,000 new cases and 2,970 deaths from this disease in
2006.1 Pennsylvania colorectal cancer incidence and mortality
rates are higher than those expected in the nation. Further,
incidence and mortality rates vary considerably across the state.
The lifetime risk of being diagnosed with colorectal cancer in the
general population is approximately 6%. More than 90% of
colorectal cancer cases are diagnosed in persons 50 years of age or
older. The risk of being diagnosed with colorectal cancer is greater
among individuals with a personal or family history of colorectal
cancer and or colorectal polyps, a personal history of inflammatory
bowel disease and certain inherited genetic characteristics, (e.g.,
familial adenomatous polyposis (FAP) and hereditary nonpolyposis
colorectal cancer (HNPCC).2

Screening and Cost-Effectiveness
Screening for colorectal cancer in the absence of symptoms
offers the potential for both primary prevention (incidence
reduction) by removing pre-cancerous polyps and secondary
prevention (mortality reduction) by detecting and treating the
disease at an early stage. The recommended screening modalities
are stool blood testing (SBT) every year, flexible sigmoidocsopy
every five years, annual SBT plus flexible sigmoidoscopy every
five years, colonoscopy every 10 years, or double contrast barium
enema every five years. Screening with colonoscopy is
recommended for those at increased risk at age 40, or 10 years
before the age at which a member of the person’s family was
diagnosed with colorectal cancer.3
The standard threshold in economic outcomes research holds
that an average cost-effectiveness ratio (ACER) of less than
$50,000 signals a relatively worthwhile economic investment.
An ACER compares the total cost of screening to the total number
of life years saved. ACERs for the most cost-effective screening
strategies are as follows: ACER for stool blood testing every year
ranges from $5,980 to $11,632; ACER for combined annual stool
blood testing and flexible sigmoidoscopy every five years ranges
from $13,922 to $24,570; ACER for colonoscopy every ten years
ranges from $14,181 to $23,570.4 Thus, the use of colorectal

tests were covered “sometimes.” A small number of insurers
restricted coverage for colonoscopy screening to enrollees who are
at increased risk. Deductibles and co-payment varied considerably
by type of screening test.5

Colorectal Cancer Treatment Costs
In 2005, there were 9,287 hospital admissions in Pennsylvania
for which colorectal cancer was the primary diagnosis.
Admissions by disease stage were as follows: Stage 1 (1%), Stage
2 (54%), Stage 3 and expired (45%). Treatment costs related to
these admissions totaled $540,533,844. Average treatment costs
increased in accordance with disease stage: Stage 1 ($36,395),
Stage 2 ($54,938), Stage 3 and expired ($62,845). In 2005, there
were also 5,327 hospital admissions in Pennsylvania for which
colorectal cancer was a secondary diagnosis. Admissions by
disease stage were as follows: Stage 1 and reported history of
colorectal cancer (1%), Stage 2 (57%), Stage 3 and expired (42%).
Treatment charges related to these admissions totaled
$222,256,770. Average treatment charges increased in accordance
with disease stage: Stage 1 and reported history of CRC
($28,400), Stage 2 ($40,248), and Stage 3 and expired ($43,944).
Overall, there were a total of 14,614 hospital admissions for which
colorectal cancer was the primary or secondary diagnosis.
Treatment charges increased in accordance with disease stage.
Total charges related to these admissions were $762,790,614.5

Capacity and Demand for
Colorectal Cancer Screening
A statewide survey of hospitals and ambulatory surgery centers
showed that there is excess capacity in the state for the
performance of colonoscopy procedures. Analysis of the survey
data also indicates that flexible sigmoidoscopy screening is not
commonly recommended or performed but there is substantial
excess capacity for the performance of this procedure. Stool blood
testing is relatively inexpensive and widely available. Screening
capacity does not present a problem. Using three scenarios, we
estimate that if the demand for all colorectal cancer screening
procedures increased by 2.5%, 5%, or 10% per year, there would
still be no capacity problem.5
continued p.11
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Domestic
Violence
infor
Same-Sex
Couples
Veteran’s Administration
National
Center
Patient Safety
Comes to Philadelphia
Research on domestic violence consistently
relationship and almost none of the
ROBERT J. WINN, MD
demonstrates the need for services in the areas
individuals sought treatment or services
INSTRUCTOR
of prevention, screening, and treatment of
related to their abuse incident.
DEPARTMENT OF FAMILY AND
abuse. However, the populations sampled for
This study indicates that domestic violence
COMMUNITY MEDICINE
these studies are almost exclusively
is at least as common in LGBT couples as
THOMAS JEFFERSON UNIVERSITY
heterosexual, and the typical victim was
in heterosexual couples and suggests that
KATIE KUPFER LOCKWOOD ’08
female. Consequently, services, legislation,
regardless of the sex of one’s partner, providers
MEDICAL STUDENT
and public opinion of who is affected by
should screen for domestic violence.
domestic violence tend to neglect same-sex
JEFFERSON MEDICAL COLLEGE
Furthermore, few of these victims report
couples. Further, this skewed perspective often
incidents to police, physicians, counselors, or
RALPH RIVIELLO, MD
dismisses the possibilities that gay men can be
lawyers. While this may suggest that the abuse
ASSISTANT PROFESSOR
victims or that lesbian women may be
is not severe enough to warrant treatment or
DEPARTMENT OF EMERGENCY MEDICINE
batterers. Existing literature suggests that rates
help, it is possible that the LGBT community’s
T
HOMAS JEFFERSON UNIVERSITY
of abuse in these populations range from 9%reluctance to disclose incidents of abuse is
41% depending of the definition of abuse.1
because of fear of a homophobic response.5
Although broad, this range is comparable to that of heterosexual
A majority of the victims in this study identified abusers as either
couples, reportedly between 2%-30% depending on several
current or past intimate partners, emphasizing that partner violence
socioeconomic factors.2,3 This article aims to quantify the number
is of greater prevalence than family, acquaintance, or stranger abuse
of lesbian, gay, bisexual, and transgender (LGBT) people in
in this population. This has significant implications for health care
Philadelphia who report to be victims of domestic violence.
providers in the screening and treatment of abuse incidents in this
To assess the problem, anonymous, self-report surveys were
population. For example, it is important to make sure that a patient
collected and analyzed over a 3-week period at the Mazzoni Center is safe to return home after discovering abusive behavior, as they
for LGBT Health and Well-Being in Center City Philadelphia. The
likely have an ongoing relationship with their abuser.
Mazzoni Center sees a broad range of patients, 50% of whom are
The results indicate a significant rate of partner abuse in the
insured and 80% of who are non-heterosexual identified. The
LGBT
community, and highlight the need for future research in
survey asked if participants had been victims of physical,
this area. This study is one step toward understanding the
psychological, sexual, and “I am scared for my safety” types of
magnitude of this problem and figuring out how best to reach this
abuse. Also collected were the gender of the abuser, relationship
overlooked community in terms of prevention, screening, and
between abuser and victim, and services sought for treatment or
treatment of partner abuse. The number of respondents and
help. The survey was adapted from the George Washington
minimal refusals to participate in this survey (less than 6% of those
University Universal Violence Prevention Screening Protocol and
asked) are suggestive of the LGBT community’s cooperation and
a study of heterosexual male domestic violence victims.4
willingness to participate in research. This will hopefully
Of the 99 people participating in the survey, 64 were male, 22
encourage other researchers to study this population in order to
were female, eight were male-to-female (MTF) transgender, and
better serve their needs. The scarcity of available abuse resources
six were female-to-male (FTM) transgender. The sexual
targeted toward the LGBT communities underscores the
orientation of the participants was predominantly gay (47), with
importance for all LGBT centers and programs to be aware of this
three lesbian, 14 bisexual, 22 heterosexual, and seven people
issue and to work toward improving these services.
unsure of their orientation. Additionally, six participants left the
sexual orientation component blank. The mean age of respondents
was 31 years, with a range from 17 to 52. Six people refused to
REFERENCES
take a survey and none of these people knew the survey was about
domestic violence at the time of refusal.
Overall, 24 respondents reported at least one type of abuse in the
past 12 months; 14 of these specifically reported partner abuse.
Abuse was reported by individuals across all sexual orientations
and gender identities, with the highest percent reported by bisexual
and transgender people. Seven of the 78 LGBT individuals said
they had been threatened with a weapon. Of this group, five were
female. Thirteen LGBT individuals reported that someone had
choked, kicked, bitten, punched, slapped, grabbed, or shoved them
in the past 12 months. Seven had had someone throw an object at
them in an attempt to hurt them, with half of this group being male
and a quarter being male transgender. Eleven of the total sample
had been afraid a current or former intimate partner would hurt
them physically. Five of individuals in this sample had been
forced to have sex and all of these respondents were women.
Interestingly, two were bisexual and three were heterosexual
women, with no lesbians reporting forced sex. Current or past
intimate partner abuse was the most common type of abuser-victim
6 June 2007
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Department of Health Policy Meeting Notes
The 16th Annual Dr. Raymond C. Grandon Lecture
May 3, 2007
Patient Safety: The Impact of Facility Design
This year’s speaker was John G. Reiling, PhD, MHA, MBA,
President and CEO of Safe by Design. His message was clear and
compelling. “See the harm, think ‘human,’ and seek techniques
and technologies to design around preventing errors.”
See the harm. The opportunity for harm in ambulatory and
inpatient care is high. There are 15 million events of harm
annually. One of 10 drugs administered is incorrect at the point of
service and, last year, 90,000 people died of hospital acquired
infections––one in 300 admissions. To appreciate the magnitude
of these statistics, compare them to deaths on domestic airline
flights (1 in 8 million flights) or the much publicized problem of
lost airline luggage (7.5 problems per 1000 passengers).
Think “human.” The Institute of Medicine report, “To Err is
Human,” acknowledged the fallacy in the belief that good doctors
and good nurses do not make mistakes. All humans make
mistakes. There are conditions under which mistakes are more
likely (e.g., fatigue, noise, multitasking) and there are conditions
that can be created to catch mistakes before they cause harm.
Seek techniques and technologies to design around preventing
errors. Fewer patients will be harmed through good hospital
design. Facilities, equipment, and technologies to support safety
begin with standardization and simplification. Many normal
hospital activities––e.g., looking for things in patient rooms and
nursing stations that vary from one to another––use up considerable
amounts of short-term memory and lead to making errors in more
important processes. “Standardization is one of the most effective
tools for creating a safe environment.”
Across the country, safe design features are being incorporated
into new and renovated facilities. Examples include:
• New inpatient facility designs feature a glass-windowed alcove
with a computer in each patient room. This allows nurses to
complete all tasks pertaining to one patient (e.g., post orders
and enter clinical data) within view of that patient and before
moving to the next. Studies show that “one-at-a-time” is more
efficient and less error prone than “batching.”
• Some hospital systems no longer use vinyl coverings on exterior
walls because the material attracts infection-causing mold.
• Some facilities have begun to use windows that enclose blinds
within the glass to reduce the surface areas that breed germs.
An organization must see harm in order to effect necessary
changes. A culture of safety that permeates the entire organization
must be created––and facility design makes it concrete.

Health Policy Forums
Pennsylvania 2020 Vision
Secretary Nora Dowd Eisenhower
Pennsylvania Department of Aging
March 14, 2007
In 2020, it is estimated that 20% of Pennsylvanians will be over
65 and 20% will be under 18. Secretary Dowd Eisenhower relayed
this unusual statistic during her presentation on the Pennsylvania
Department of Aging (DOA) and the Pennsylvania 2020 Vision project.
The DOA was created in 1978 to provide a greater focus on
issues surrounding the aging population. Under the DOA, the
Pharmaceutical Assistance Contract for the Elderly (PACE)

program was developed and managed. One of the first of its kind
in the country, PACE has been providing income-based assistance
for over 20 years. Funding for this and many other Department
programs comes from the profits from the PA Lottery. Beyond the
prescription assistance, as a rich data resource, PACE provides
important drug detailing information for providers and allows for
targeted improvement efforts for doctors.
Long Term Living (LTL) management also comes under the
auspices of the DOA. Nearly 80% of PA state dollars for LTL goes
toward institutional care, with the remaining 20% spent on care in
the home or community. This breakdown is markedly different
than that in other states, such as Oregon, which uses only 20% of
state funds on institutional care. The Governor has set a goal of
balancing these expenditures, using waivers. Additionally, the
Governor’s LTL Council, consisting of various state departments
such as Transportation, Welfare, Health, and Economic
Development, is looking at how we can better provide care and
allow elderly to live in community settings versus institutions.
Secretary Dowd Eisenhower went into detail about the changing
demographics of Pennsylvania residents and described the goals of
the Pennsylvania 2020 Vision as being:
1) Assess challenges and opportunities presented by these shifts and
2) Develop Agency Response Plan (ARP) to plan for
programmatic and fiscal impacts of these changes.
To view slides or listen to Secretary’s Dowd Eisenhower’s
presentation in its entirety, please visit: http://www.jefferson.edu/
dhp/education_ls.cfm
Strengthening the Mid-Atlantic Region for Tomorrow (SMART)
Bob Carullo
Executive Director, SMART
April 11, 2007
SMART, a grassroots organization that sprung from the
technology community in the mid-1990’s, pulls together a
congressional caucus, the federal executive branch, states and
regional technology communities. Currently a 4-state science and
technology authority, SMART is working to expand to at least 4
additional states across the nation. SMART has federal budget line
items through the Departments of Commerce and Defense.
Recognizing that there are limited national assets for technology,
SMART developed its mission: Integrated collaboration on
science and technology issues that lead to regional technology
enterprise and intellectual vitality.
Members of SMART understand that you get out of the
organization what you put into it. Its primary purpose is to help
facilitate regional solutions for national and international issues.
For example, the congressional caucus provides legislative support
and can assist in gaining government endorsement for science and
technology advancements.
SMART supports a variety of activities including:
• Annual Conventions: Tech Trends, Capital Forums, and
SMART PROC (Procurements)
• Technology fairs in local congressional regions.
• Staffer series: quarterly technology topics requested by
staffers, e.g., stem cell research
• State-Wide Meetings
For more detailed information on SMART visit:
http://www.smartstates.com/
To learn more about the SMART PROC meeting visit:
http://www.smartproc.com/
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Potential Impact of Advance Directive Law Act 169 on Decisions and
Care for Patients at End of Life: Reflections of Ethics Consultants
Patients' participation in end of life
treatment decisions has received increasing
attention in recent years as legal, ethical,
and social pressures combine to support a
more active role for patients. Despite
overwhelming societal support for the view
that individual patients should be involved in
treatment decisions at the end of life, many
problems remain in implementing this
perspective.

ETIENNE PHIPPS, PHD
DIRECTOR, EINSTEIN CENTER FOR
URBAN HEALTH POLICY & RESEARCH

consider this on equal terms with other
life-sustaining treatments that can be
foregone, AN/H are not considered as a
presumed treatment to be withheld or
RICHARD ALLMAN, MD
withdrawn unless the patient specifically
CHAIRMAN, DIVISION OF RHEUMATOLOGY
states otherwise in writing. Thus, the new
CHAIRMAN OF THE MOSSREHAB
law seems to imply a legal obligation to
ETHICS COMMITTEE
continue AN/H unless stipulated by the
ALBERT EINSTEIN HEALTHCARE NETWORK advance directive. At the same time, the
text indicates that families and providers
may
be
able
to
discern
a patient’s wishes regarding AN/H, if it
Ethical and legal guidelines support the individual’s role in
can
be
derived
from
other
information about that patient, and
medical decision making at end of life, including decisions to
withheld
or
withdrawn
based
on those inferences.
forgo life-sustaining treatment, even when it may result in death.
Advance directives, such as living wills, were legislated in 1991
with the Patient Self-Determination Act (PSDA) and were aimed
at strengthening the rights of patients to continue to express their
wishes regarding the use of life-sustaining measures should they
become terminally-ill or permanently unconscious.1,2 In the
years since that legislation was enacted, however, a number of
studies have demonstrated that only a small percentage of
patients have advance directives, and these percentages are even
smaller among minority patients.3,4 However, Teno, in a
national mortality follow-back survey (N=1587) 10 years after
the enactment of PSDA, found that a huge 71% of the 1,587
people who died (at home, in nursing home, or in hospital) were
said to have had an advance directive. Further, individuals who
had an advance directive were less likely to have a feeding tube,
or use a respirator in the last month of life compared with those
who did not.5
On November 30, 2006, Act 169 (The General Assembly of
Pennsylvania Senate Bill No. 628 session of 2005) was signed
into law by Pennsylvania Governor Ed Rendell. This Act, like
most laws, is the culmination of a process of negotiation and
compromise. It includes some changes designed to assist
providers, specifically around advance health care directives
and health care decision making for patients incapable of
directing care.
In the new law, advance directives are valid now when the patient
is determined to be incompetent, is permanently unconscious, or
has an end-stage medical condition. Incompetency is defined as:
A condition in which an individual—despite being provided
appropriate medical information, communication supports, and
technical assistance—is documented by a health care provider to
be unable to: 1) understand the potential material benefits, risks,
and alternatives involved in a specific proposed health care
decision; 2) make that health care decision on his own behalf; or
3) communicate that health care decision to any other person. In
the past, the term “terminal” was linked to a 6-month prognosis,
which meant that some patients with stroke and Alzheimer’s
patients did not meet that requirement and thus were excluded
from “benefiting” from having their documented wishes
followed. To its credit, the new law streamlines the process for
declaring a patient to be permanently unconscious or for being
in an end-stage condition, no longer requiring confirmation by a
second physician.
Of distinction in the PA law is that artificial nutrition and
hydration (AN/H) are given heightened attention. Rather than
8 June 2007

In another notable aspect of the law, the new term “health
care representative” is introduced to refer to a class of potential
decisionmakers for decisionally-incapable patients. These are
individuals who do not need to be formally designated (unlike a
health care power of attorney), but are assumed to be determined
through family lines to close friends. These individuals can also
consent to ongoing treatment and forgoing of medical care.
However, unlike the health care agent with a health care power
of attorney document, health care representatives, according to
this law, can only provide consent to forgo medical care when
the patient meets the living will requirements; that is
permanently unconscious and in end stage disease.
The obligation of health providers to offer care that is more
beneficial than burdensome and to provide comfort care at end
of life is one that challenges many of us involved in ethics
consultation and care of patients at end of life. Futile care is
highly controversial because of the lack of consensus about
whom or what defines futile care. The current Act reiterates that
health care providers are not required to provide futile care but
should “in general” have consent to withhold or withdraw care
considered to be futile.
Where the new statute falls short of meeting the ethical needs
of patients and health care providers “in the trenches” relates to
its silence about serving the needs of the most vulnerable cohort
of patients, those lacking decision making ability and having no
advance directive or available family members or others who
know their values.
There are no easy answers; as Veatch has described, “alone,
incompetent and dying” is as bad as it gets.6 Ideally for these
patients, a court appointed guardian seems reasonable, but is
impractical due to expense and time. Too often a patient dies
before a guardian can decide and advocate for the patient.
Further, the guardians appointed often assume the minimalist
role of merely giving consent for continued treatment and
intervention without any consideration of whether that for which
they consent serves any human need for the patient. Patients
lacking decision makers cannot be enrolled in hospice programs,
where such high quality end-of-life care would be delivered.
The law would be far more valuable to these patients lacking
decision making ability were it to acknowledge the reality that
where no judgment can be made of the patient’s values,
including looking for substitute markers of values such as
continued p. 9
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religious preference, retreat to a ‘best interest’ standard, with
of proportionate
benefits to burdens
for the patient,
is
balance
Veteran’s
Administration
National
Center
more likely to result in improved quality care at the end of life.
While the notion of autonomous decision making is one that
is challenged daily in clinical settings across the country as
decisions are made for dying patients by others, there is still an
underlying societal belief in the importance of individual
dignity and the rights of individuals to have a say in their
medical treatment. Ensuring that medical care at end of life
reflects respect for persons and supports a peaceful and
dignified death remains a formidable challenge for policy
makers and health care providers.
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Thomas Jefferson and Widener Universities Announce
Joint Degree Program in Law and Public Health
Thomas Jefferson University (TJU) and Widener University
have established two new joint degree programs in law and
public health. The programs were approved last month by the
TJU Board of Trustees. Candidates for the joint degree may
enter the program from the Master in Public Health (MPH)
program at Jefferson or from the Widener Law School and may
start in the next academic year. Enrollees in this program will
obtain one of two joint degrees, a Doctor of JurisprudenceMaster of Public Health degree (JD-MPH) or a Master of
Jurisprudence-Master of Public Health degree (MJ-MPH).
Individuals with joint degrees are being sought after by
hospitals, health departments, health associations, voluntary
organizations, and other health institutions. MJ-MPH candidates
are typically individuals who seek a career in health administration
and will benefit from expertise in legal topics like confidentiality,
bioethics, risk management, disability law, etc. Many MJ

graduates are nurses. JD-MPH candidates are typically
individuals who sit for the bar exam and become legal counsels
to medical institutions, businesses, and organizations. They may
choose private law practice. The combination of a legal education
with public health core subjects like biostatistics, epidemiology,
health behavior, management and policy, and environmental
health is of high value to health associations and institutions.
Joint degree students will study at both TJU in Philadelphia
and Widener University in Delaware over the course of several
years. The MPH may be completed in a little over a year and a
joint degree will require 3-7 years, depending on which degree
the student chooses and whether the student studies on a full- or
part-time basis. Students will apply to both schools. Information
may be obtained from the admissions office at Widener Law
School or through Jefferson College of Graduate Studies. For
more information, contact Jennifer Ravelli at 215-503-0174.
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Transforming Healthcare:
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Themes
from the National
5th Annual
National
MD/MBA
Conference
The 5th Annual MD/MBA Conference for
School of Medicine and the Paul Merage
JEFF CLOUGH ’08
program directors, faculty, students, and
School of Business at the University of
ERIC MOSKOWITZ ’09
alumni was held on April 13-15, 2007 in
California – Irvine, provided the annual
MD/MBA CANDIDATES
Houston, TX. Sponsored this year by
update of MD/MBA programs. The
JEFFERSON MEDICAL COLLEGE/
Baylor College of Medicine and Jones
number of MD/MBA programs remains
WIDENER UNIVERSITY
Graduate School of Management, Rice
constant at 54, as reported in at the 2006
University, the conference focused on
meeting. However, the total number of
physician leadership in academic medical centers and hospitals.
MD/MBA students is unknown, since no formal reporting/
Speakers detailed how they utilized their combined medical and
tracking system is currently in place. Dr. Chandler expressed a
business training to positively impact their organizations and
desire to engage all of the programs in the organization’s efforts
patients. The diverse examples include activities such as leading
to accurately determine the size and characteristics of these
department and hospital-wide quality improvement efforts,
programs. She encouraged program directors, as well as
planning system-wide resource allocation, and bringing
students, to provide her with updated contact information,
promising technologies to market.
enrollment statistics, and ideas for the future of the organization,
(mchandle@uci.edu).
In his keynote address, Stephen Spann, MD, MBA, professor
and chairman of the Department of Family and Community
Medicine at the Baylor College of Medicine, stressed the need
for physician-led transformation of health care given the high
costs and quality gaps of the U.S. health care system. There was
general consensus that physicians with business training are
primed to lead this transformation, given their enhanced leadership
and management skills. However, there was much debate about
the specifics of how students could lead this transformation and
how to monitor the impact of MD/MBAs. Students voiced
concerns about opportunities to use and demonstrate the value of
business education throughout their medical training and early
careers. Faculty stressed the need to track MD/MBA students to
demonstrate and optimize the impact of these programs.
Maria Chandler, MD, MBA, president of the national
organization of MD/MBA programs and faculty advisor for the

Several actionable steps emerged from the conference.
Merilee Perkins of Dartmouth Medical School presented a
revamped version of the National Association of MD/MBA
Students website (http://dms.dartmouth.edu/mdmbas/). The site
contains regularly updated information such as MD/MBA
profiles and a discussion forum. The Dartmouth Medical
School/Tuck School of Business MD/MBA program maintains
the site, with support from other programs. Current and past
students are encouraged to upload their information to the site.
Another goal of the student association is to develop a database
of current and former students from all joint MD/MBA
programs. Jefferson Medical College has volunteered to serve
as an administrative home for this database. Results from these
tracking efforts will be reported at the next year’s conference to
be held spring 2008 in Washington, DC.

New Publications from the Department of Health Policy
Blackstone EA, Fuhr JP, Jr. Generic
biopharmaceutical drugs: an economic and
policy analysis. Biotechnology Healthcare.
2007;4(1):43-48.

Hansen-Turton T, Ryan S, Miller K, Counts
M, Nash DB. Convenient care clinics: the
future of accessible health care. Dis Manag.
2007;10(2):61-73.

Clarke JL, Meiris DC. Building bridges:
integrative solutions for managing complex
comorbid conditions. Am J Med Qual.
2007;22(2S):5S-16S.

Lee SP, Clarke JL. Literature review. Am J
Med Qual. 2007;22:218-220.

Clough J, Nash DB. Health care governance
for quality and safety: the new agenda. Am J
Med Qual. 2007;22:203-213.
Coberley CR, McGinnis M, Orr PM, Coberley
SS, Hobgood A, Hamar B, Gandy B, Pope J,
Hudson L, Hara P, Shurney D, Clarke JL,
Crawford A, Goldfarb NI. Association
between frequency of telephonic contact and
clinical testing for a large, geographically
diverse diabetes disease management
population. Dis Manag. 2007;10(2):101-109.
Fuhr JP, Jr. The impact of health benefits
mandates: the California review program.
Health Watch. January 2007:20-21.
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Lofland JH, Gagne JJ, Pizzi LT, Rupnow M,
Silberstein SD. Impact of topiramate migraine
prophylaxis on workplace productivity:
results from two US randomized, doubleblind, placebo-controlled, multicenter trials.
J Occup Environ Med. 2007;49(3):252-257.

Nash DB. MANA From Heaven.
Biotechnology Healthcare. 2007;4(2):6.
Nash DB. PNWER Power P&T.
2007;32(1):7.
Nash DB. Toot Your Own Horn Two. P&T.
2007;32(2):65.
Nash DB. Medicare and P4P. P&T.
2007;32(3):123,181.
Nash DB. HealthCast 2020. P&T.
2007;32(4):192.

Meyers R, Sarfaty M. Various Aspects of
Colorectal Cancer Screening.
Pennsylvania Legislative Budget and Finance
Committee (LBFC). Reports Released:
Health and Welfare: February 2007.
http://lbfc.legis.state.pa.us/

Sarfaty M. How to Increase Screening for
Colorectal Cancer in Practice: A Primary
Care Clinician’s Evidence-Based Toolbox
and Guide. National Colorectal Cancer
Roundtable. 2006: 142 pp; www.cancer.org/
colonmd. For Your Practice.

Moskowitz EJ, Goldfarb NI. Literature
review. Am J Med Qual. 2007;22:133-135.

Sarfaty M. Quality in the delivery of
preventive services: The National Colorectal
Cancer Roundtable. Am J Med Qual.
2007;22(2):127-132.

Nash DB. Say What? Biotechnology
Healthcare. 2007;4(2):6.

Yuen EJ. Spirituality, religion, and health.
Am J Med Qual. 2007;22(2):77-79.

A Study of Colorectal Cancer continued from p.5

Conclusions
serve a basic roleNational
in facilitating Center
Primary care physicians
Veteran’s
Administration
population use of recommended colorectal cancer screening tests
and follow up of abnormal screening test findings. Physicians
most commonly recommend stool blood tests and colonoscopy
screening. Hospitals and ambulatory surgery centers routinely
provide flexible sigmoidoscopy and colonoscopy screening. It
appears that sigmoidoscopy is currently used infrequently for
colorectal cancer screening purposes in Pennsylvania. The
capacity for endoscopy (flexible sigmoidoscopy and colonoscopy)
screening in the state is substantial, however, and should
accommodate increased demand without placing a strain on
institutions that provide these procedures.
Any increase in demand for colorectal cancer screening resulting
from these efforts is not expected to have a significant impact on
the pricing structure or safety profile of colonoscopy or other
screening procedures. Increases in screening rates can be expected
to reduce both the incidence and mortality from colorectal cancer.
Higher levels of screening use would be expected to reduce the
costs of medical care for colorectal cancer. Increased colorectal
cancer screening use could substantially reduce the personal and
economic burden of colorectal cancer for citizens of the
Commonwealth.
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HEALTH POLICY FORUM: FALL 2007
The Forum meets on the second Wednesday of each month (September-June) from 8:30 a.m. to 9:30 a.m.
in Conference Room 218, Curtis Building, 1015 Walnut Street, Philadelphia, PA. A light breakfast will be served.
September 12, 2007
Household Survey and Consumer Driven Health Care
Cindy Fillman
Director, Office of Consumer Liaison
Commonwealth of Pennsylvania

October 10, 2007
Pharmaceutical Management Program & Business
Strategy with Science and Technology
Kevin Caviston
Director, Drexel MBA Pharmaceutical Management
Drexel University

Department of Health Policy Presentations
Gagne JJ, Maio V, Rabinowitz C, Louis
DZ. Prevalence of Clinically Important
Potential Drug-Drug Interactions in
Regione Emilai Romagna, Italy. 12th
Annual Meeting of the International
Society Pharmacoeconomics and
Outcomes Research, May 21, 2007,
Washington, DC.

Lee SP, Bunz T, Gagne JJ, Maio V,
Goldfarb NI. Determinants of Total
Hospital Costs Among Inpatients with
Candidemia. 12th Annual Meeting of the
International Society Pharmacoeconomics
and Outcomes Research, May 22, 2007,
Washington, DC.

Short J, Talati A, Maio V, Pizzi L,
Lagermasini C, Goldfarb NI. Evaluation
of the Impact of the Philadelphia
Community Pharmacy Network Program.
American Pharmacists Association 2007
Annual Meeting, March 18, 2007,
Atlanta, GA.

Benefits College Update
Now in its third year, the College for Advanced
Management of Health Benefits is a national Value-Based
Purchasing training program for employee benefit managers,
other health benefit purchasers, and their agents. The
program, developed by the Department of Health Policy in
collaboration with the HealthCare21 Business Coalition in
Tennessee, and the National Business Coalition on Health,
seeks to provide benefit purchasers with the latest
information on how to effectively purchase and manage

benefits so as to promote value and quality in health care.
So far this year programs were held in mid-March in Las
Vegas and early June in Nashville.
The remaining program of the year is scheduled for:
September 24-26 in Columbus, OH.
For more information, or to request a brochure, please
contact: neil.goldfarb@jefferson.edu.
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